The University of Chicago Header Logo

Connection

Vishal Gupta to Aged

This is a "connection" page, showing publications Vishal Gupta has written about Aged.
Connection Strength

0.248
  1. The Collaborative Ocular Tuberculosis Study (COTS)-1 Report 3: Polymerase Chain Reaction in the Diagnosis and Management of Tubercular Uveitis: Global Trends. Ocul Immunol Inflamm. 2019; 27(3):465-473.
    View in: PubMed
    Score: 0.043
  2. Continuous progression of tubercular serpiginous-like choroiditis after initiating antituberculosis treatment. Am J Ophthalmol. 2011 Nov; 152(5):857-63.e2.
    View in: PubMed
    Score: 0.028
  3. Sympathetic ophthalmia: epidemiology and cohort-based assessment of clinical outcomes. Br J Ophthalmol. 2025 Jan 28; 109(2):223-227.
    View in: PubMed
    Score: 0.018
  4. Impact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALL. Blood Adv. 2024 Dec 10; 8(23):6139-6147.
    View in: PubMed
    Score: 0.017
  5. Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL. J Clin Oncol. 2025 Feb 10; 43(5):558-566.
    View in: PubMed
    Score: 0.017
  6. Outcomes after giant peripheral retinotomy and anterior flap retinectomy for rhegmatogenous retinal detachments with advanced proliferative vitreoretinopathy using small gauge vitrectomy. Indian J Ophthalmol. 2024 Dec 01; 72(12):1772-1779.
    View in: PubMed
    Score: 0.017
  7. THE COLLABORATIVE OCULAR TUBERCULOSIS STUDY (COTS)-1: A Multinational Review of 251 Patients With Tubercular Retinal Vasculitis. Retina. 2019 Aug; 39(8):1623-1630.
    View in: PubMed
    Score: 0.012
  8. Clinical Characteristics and Treatment of 308 Panuveitis Patients over 10 Years: Results from the KKESH Uveitis Survey Study Group. Ocul Immunol Inflamm. 2019; 27(8):1296-1304.
    View in: PubMed
    Score: 0.011
  9. Global Variations and Challenges With Tubercular Uveitis in the Collaborative Ocular Tuberculosis Study. Invest Ophthalmol Vis Sci. 2018 08 01; 59(10):4162-4171.
    View in: PubMed
    Score: 0.011
  10. Role of CT Chest and Cytology in Differentiating Tuberculosis from Presumed Sarcoidosis in Uveitis. Ocul Immunol Inflamm. 2019; 27(7):1041-1048.
    View in: PubMed
    Score: 0.011
  11. Clinical Features and Outcomes of Patients With Tubercular Uveitis Treated With Antitubercular Therapy in the Collaborative Ocular Tuberculosis Study (COTS)-1. JAMA Ophthalmol. 2017 12 01; 135(12):1318-1327.
    View in: PubMed
    Score: 0.011
  12. Epidemiology and clinical features of inflammatory retinal vascular occlusions: pooled data from two tertiary-referral institutions. Clin Exp Ophthalmol. 2018 01; 46(1):62-74.
    View in: PubMed
    Score: 0.010
  13. Safety and Outcome of Microincision Vitreous Surgery in Uveitis. Ocul Immunol Inflamm. 2017 Dec; 25(6):775-784.
    View in: PubMed
    Score: 0.010
  14. Diagnostic Challenges in Inflammatory Choroidal Neovascular Membranes. Ocul Immunol Inflamm. 2017 Aug; 25(4):554-562.
    View in: PubMed
    Score: 0.010
  15. Clinical Outcomes of Patients with Vogt-Koyanagi-Harada Disease Over 12 Years at a Tertiary Center. Ocul Immunol Inflamm. 2016 Oct; 24(5):521-9.
    View in: PubMed
    Score: 0.009
  16. Six-month visual outcome after pars plana vitrectomy in proliferative diabetic retinopathy with or without a single preoperative injection of intravitreal bevacizumab. Int Ophthalmol. 2012 Apr; 32(2):135-44.
    View in: PubMed
    Score: 0.007
  17. Ocular signs predictive of tubercular uveitis. Am J Ophthalmol. 2010 Apr; 149(4):562-70.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.